✦ LIBER ✦

Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study

✍ Scribed by Monteiro, P.; Perez, I.; Laguno, M.; Martinez-Rebollar, M.; Gonzalez-Cordon, A.; Lonca, M.; Mallolas, J.; Blanco, J. L.; Gatell, J. M.; Martinez, E.

Book ID: 126608699
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 258 KB
Volume: 69
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dkt406

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral rebound after switch to maraviroc/

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

✍ Nozza, S.; Bigoloni, A.; Calcagno, A.; Galli, L.; Pignataro, A. R.; D'Avolio, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 113 KB

A Switch in Therapy to a Reverse Transcr

A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study

✍ Ofotokun, Ighovwerha; Sheth, Anandi N.; Sanford, Sara E.; Easley, Kirk A.; Shenv 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 358 KB

High rate of virologic suppression with

High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil

✍ Vidal, José Ernesto; Song, Alice Tung Wan; Matos, Maria Laura; Bartmann, Daniel; 📂 Article 📅 2013 🏛 SciELO 🌐 English ⚖ 324 KB

Ritonavir-boosted lopinavir plus nucleos

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study

📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 311 KB

Erratum in «High rate of virologic supre

Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil»

✍ Ernesto Vidal, José; Tung Wan Song, Alice; Laura Matos, Maria; Bartmann, Daniel; 📂 Article 📅 2013 🏛 SciELO 🌐 English ⚖ 116 KB